Phase III long-term administration study of Effexor XR [venlafaxine extended-release] for the treatment of depression

Trial Profile

Phase III long-term administration study of Effexor XR [venlafaxine extended-release] for the treatment of depression

Completed
Phase of Trial: Phase III

Latest Information Update: 23 May 2007

At a glance

  • Drugs Venlafaxine (Primary)
  • Indications Major depressive disorder
  • Focus Adverse reactions
  • Sponsors Wyeth
  • Most Recent Events

    • 23 May 2007 Status changed from recruiting to completed.
    • 28 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top